Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DBT1H4
|
|||
| Drug Name |
CC100
|
|||
| Indication | Amyotrophic lateral sclerosis [ICD-11: 8B60.0; ICD-9: 335.2] | Phase 1 | [1] | |
| Company |
Chemigen
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03049046) CC100: Phase 1 Multiple-Dose Safety and Tolerability in Subjects With ALS (CC100B). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.